Variation in the phenotypic expression of beta-glucuronidase deficiency

Area of Science:

• Biochemistry
• Genetics
• Metabolic Disorders

Background:

• Beta-glucuronidase is crucial for glycosaminoglycan degradation.
• Deficiency leads to accumulation of dermatan and heparan sulfates.
• Mucopolysaccharidoses are a group of genetic disorders.

Purpose of the Study:

• To investigate the clinical and biochemical findings in two patients with beta-glucuronidase deficiency.
• To analyze the impact of enzyme deficiency on glycosaminoglycan metabolism.

Main Methods:

• Enzyme activity assays in serum, leukocytes, and fibroblasts.
• Analysis of urinary mucopolysaccharides.
• Measurement of glycosaminoglycan accumulation in cultured fibroblasts using 35-SO-4 uptake.

Main Results:

• Confirmed beta-glucuronidase deficiency in all tested tissues.
• Identified impaired degradation of dermatan sulfate and heparan sulfate.
• Demonstrated excess glycosaminoglycan accumulation in patient fibroblasts.

Conclusions:

• Beta-glucuronidase deficiency underlies the observed phenotypes, including mucopolysaccharidosis and vascular abnormalities.
• The findings highlight the critical role of beta-glucuronidase in preventing lysosomal storage diseases.